SC Novartis judgment is pro-innovation


In this article in today’s Indian Express, I argue that the recent Supreme Court judgment in the Novartis’ case is very much pro-innovation, but tries to weed out marketing gimmicks from patent protection.
This blog has previously dealt with the issue here
Subscribe
Notify of
guest

This site uses Akismet to reduce spam. Learn how your comment data is processed.

0 Comments
Inline Feedbacks
View all comments